Stockreport

BRIEF-FDA Accepts For Review Sanofi's Supplemental Biologics License Application [Reuters]

Sanofi - American Depositary Shares  (SNY) 
US:NYSE Investor Relations: sanofi.com/en/investors
PDF BRIEF-FDA Accepts For Review Sanofi's Supplemental Biologics License Application | Reuters Reuters Staff 1 Min Read April 25 (Reuters) - SANOFI SA: * FDA ACCEPTS FOR REV [Read more]